摘要
Postpartum septic complications remain a major cause of maternal morbidity and mortality despite substantial advances in antimicrobial therapy, surgical management, and infection prevention strategies. Postpartum sepsis is defined as a systemic infectious and inflammatory response developing within 42 days after the termination of pregnancy. Its clinical spectrum encompasses endometritis, surgical site infections, parametritis, pelvic abscess, peritonitis, septic thrombophlebitis, sepsis, and septic shock, whereas timely diagnosis is often complicated by physiological postpartum changes capable of masking the early manifestations of infection. Clinical presentation also varies according to the causative pathogen, localization of the infectious process, and maternal immune reactivity.The aim of the study was to summarize current evidence regarding the etiology, pathogenesis, risk factors, diagnosis, and treatment of postpartum septic complications in accordance with contemporary international guidelines and findings reported in recent studies..Material and methods. A structured analysis of the major forms of postpartum infections, contemporary approaches to patient management, current antibacterial treatment regimens, and potential surgical interventions was conducted. Particular attention was directed toward current etiological factors associated with the development of postpartum septic complications, algorithms for the early identification of sepsis and assessment of disease severity, together with emerging trends related to antimicrobial resistance, advances in diagnostic technologies, and implementation of novel management models. Literature retrieval was performed using the PubMed, MEDLINE, and Embase scientometric databases, whereas the review covered publications from the previous decade.Results. The principal preventive strategies capable of reducing the incidence of severe postpartum infections were identified. Postpartum septic complications remain a major contributor to maternal mortality and severe maternal morbidity worldwide despite continuous advances in surgical techniques, infection control, and pharmacotherapy. Their clinical spectrum encompasses endometritis, surgical site infections, parametritis, pelvic abscesses, peritonitis, septic thrombophlebitis, as well as severe clinical forms, including sepsis and septic shock. Particular clinical challenges are associated with polymicrobial and antibiotic-resistant infections, together with rapidly progressive forms requiring immediate intensive care. The article summarizes current evidence regarding the etiological structure of postpartum infections, major risk factors, pathogenetic mechanisms, and contemporary diagnostic algorithms, while also addressing specific clinical features of the postpartum period that may hinder the early recognition of sepsis. Current approaches to antibacterial therapy are reviewed, including empirical treatment regimens, therapeutic adjustment according to microbiological findings, and principles of infusion and oral therapy. Special attention is devoted to the role of surgical intervention, methods of source control, management algorithms for severe conditions, and intensive supportive therapy. Contemporary trends are additionally considered, particularly the increasing prevalence of antimicrobial resistance, the introduction of novel diagnostic biomarkers, the refinement of prognostic models, and the potential application of early warning systems and artificial intelligence technologies. The article also presents current preventive strategies aimed at reducing the incidence of septic complications, particularly following operative delivery.Conclusion. Postpartum septic diseases remain a significant challenge in modern obstetrics. Early diagnosis, timely initiation of adequate treatment, effective control of the infectious source, and comprehensive therapy constitute the principal components of successful management. Contemporary diagnostic and therapeutic approaches allow a reduction in the incidence of severe clinical forms and contribute to the prevention of maternal complications.